Lawmakers called for strengthening U.S. life sciences companies and safeguarding...
Smoking has surpassed injecting as the most common way of taking drugs in U.S. o...
On Tuesday, two different proposed insurance plan acquisitions on different side...
A small but rapidly growing number of U.S. adolescents began treatment with Novo...
The results of Alnylam Pharmaceuticals’ Phase 3 cardiovascular study was already...
The leading chronicler of presidents and health ponders the question: How old is...
Dorit Donoviel and her team at the Translational Research Institute for Space He...
The FDA's approval of Aurlumyn (ilosprost) culminates decades of research that h...
Dragonfly Therapeutics has entered a clinical collaboration with Gilead Sciences...
The US FDA has granted orphan drug designation to Ionis Pharmaceuticals’ olezars...
Xyphos Biosciences has entered an agreement with Kelonia Therapeutics to develop...
GSK has successfully concluded the acquisition of Aiolos Bio in a deal that coul...
The success of recent trials treating mental health problems with psychedelic th...
MYK-224 is under clinical development by Bristol-Myers Squibb and currently in P...
Despite failing its primary endpoint in the EMBARK confirmatory study, Elevidys’...
This positive news comes after Otsuka’s Phase III Alzheimer’s agitation trial fa...
